FAQs Patent Questions
Question:The Patent Cooperation Treaty facilitates the filing of applications for patents, it is presently adhered to by over 124 countries
Answer: Another treaty, known as the Patent Cooperation Treaty, was negotiated at a diplomatic conference in Washington, D.C., in June of 1970. The treaty came into force on January 24, 1978, and is presently adhered to by over 124 countries, including the United States. The treaty facilitates the filing of applications for patent on the same invention in member countries by providing, among other things, for centralized filing procedures and a standardized application format.
Question:What is a regulatory review period determination?
Answer:
The regulatory review period is the basis for patent extension. Basically, a regulatory review period is composed of two parts: a testing phase, and an approval phase. The testing phase for a human drug product is the period between the effective date of an investigational product exemption (Investigational New Drug Application) and the initial submission of the marketing application (New Drug Application).
Question:"A Patent does not grant the right to make
Answer:
use or sell the invention but only grants the exclusive nature of the right."
Bookmark: 
Permalink: http://S-0.ORG/tnetZwQ
| Did You Know? |
|
A patent protects your invention.
A patent for an invention is a grant of property rights by the U.S. Government through the U.S. Patent and Trademark Office. The patent grant excludes others from making, using, or selling the invention in the United States. The terms "Patent Pending" and "Patent Applied For" are used to inform the public that an application for a patent has been filed. Patent protection does not start until the actual grant of a patent. Marking of an article as patented, when it is not, is illegal and subject to penalty.
|
Contact our Patent Professionals to ensure you complete the patent
filing process correctly or for violation of your patent rights.
|